BioTuesdays

Category - Executive Moves

Evotec
Executive Moves

Dr. Ingrid Müller joins Evotec as COO

Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT) has appointed Dr. Ingrid Müller as Chief Operating Officer (COO), effective May 1, 2026. Dr. Müller brings to the role more than 20 years of international leadership...

April 15, 2026
Executive Moves

Prelude appoints Dr. Charles Morris as CMO

Prelude Therapeutics (NASDAQ: PRLD) has appointed Dr. Charles Morris as chief medical officer (CMO), effective April 20, 2026. Dr. Morris is a medical oncologist with more than 30 years of oncology drug development...

April 15, 2026
Evotec
Executive Moves

Evotec appoints Dr. Ashiq H. Khan as CCO

Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT) has appointed Dr. Ashiq H. Khan as EVP global head, chief commercial officer (CCO). Dr. Khan brings more than 15 years of international leadership experience in...

April 1, 2026
Executive Moves

Wang Haijiao joins Fangzhou as CEO

Fangzhou (HKEX: 06086) has announced the appointment of Wang Haijiao as chief executive officer (CEO) and executive director, effective today. Mr. Wang’s nearly 20 years of extensive healthcare industry experience in...

March 26, 2026
Evolent-Health-Logo
Executive Moves

Evolent names Archie Mayani as CPO

Evolent Health (NYSE: EVH) has announced the appointment of healthcare technology leader and AI innovator, Archie Mayani, as chief product officer (CPO). Ms. Mayani brings more than two decades of leadership experience...

March 19, 2026
mindmaze therapeutics
Executive Moves

MindMaze appoints Zach Henderson as CEO

MindMaze Therapeutics (SIX: MMTX) has announced the appointment of health tech veteran Zach Henderson as chief executive officer (CEO). With more than 30 years of experience scaling healthcare technology platforms and...

March 12, 2026